Dergiler / Eurasian Journal of Medicine and Oncology / 2019 / Cilt: 3 - Sayı: 3

Interstitial Lung Disease in Dermatomyositis Complicated by Right Ventricular Thrombus Secondary to Macrophage Activation Syndrome

Sayfa
219–223
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Transthoracic echocardiogram revealed thrombus in right ventricle which was the result of prothrombotic state.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Course of dermatomyositis (DM) can be complicated by multi organ failure, by complex pathophysiological mechanisms involving auto antibodies.
📊
Temel Bulgular & Veri:Pulmonary complications are the leading cause of mortality, accounting for 30% deaths.
💡
Sonuç & Katkı:Transthoracic echocardiogram revealed thrombus in right ventricle which was the result of prothrombotic state.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Course of dermatomyositis (DM) can be complicated by multi organ failure, by complex pathophysiological mechanisms involving auto antibodies. Pulmonary complications are the leading cause of mortality, accounting for 30% deaths. There is a strong association between DM and interstitial lung disease (ILD); clinically amyopathic dermatomyositis (CADM) has stronger association with ILD as compared to classic form of DM. ILD can be in the form of fibrosing alveolitis, interstitial pneumonia and desquamative interstitial pneumonia or diffuse alveolar hemorrhage. Auto antibodies linked to ILD are anti Jo-1, PL12, PL7, EJ, and OJ and anti Mi 2. Our case describes a fifty three years old woman who presented with symptoms of lower respiratory tract infection, diagnosed with CADM on the basis of typical skin rash and polyarthritis and anti-CADM 140 antibodies. Systemic steroid therapy (initiated after ruling out sepsis) failed to provide improvement. Medical course was complicated by multisystem involvement (respiratory failure, cerebral edema, renal failure, coagulopathy, hepatic failure and thromboembolism). Transthoracic echocardiogram revealed thrombus in right ventricle which was the result of prothrombotic state.

🔖

Bu Makaleye Atıf Yap

VASUDEV, R., PAUL, N., CHANDRAN, C. (2019). Interstitial Lung Disease in Dermatomyositis Complicated by Right Ventricular Thrombus Secondary to Macrophage Activation Syndrome. Eurasian Journal of Medicine and Oncology, Cilt: 3 - Sayı: 3, 219–223. https://ajindex.com/articles/125643

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (15)

  1. Ang P, Sugeng MW, Chua SH. Classical and amyopathic dermatomyositis seen at the National Skin Centre of Singapore: a 3-year retrospective review of their clinical characteristics and association with malignancy. Ann Acad Med Singapore 2000
  2. 219–23. 2. Margo J. Reeder, David A. Wetter, Xujian Li, Mark D. P. Davis. Incidence of Dermatomyositis and Clinically Amyopathic Dermatomyositis: A Population-Based Study in Olmsted County, Minnesota. Arch Dermatol 2010
  3. 26–30. 3. Marie I Curr Morbidity and mortality in adult polymyositis and dermatomyositis. Rheumatol Rep 2012
  4. 275–85. 4. Airio A, Kautiainen H, Hakala M Clin Rheumatol. Prognosis and mortality of polymyositis and dermatomyositis patients 2006
  5. 234–9. 5. Li L, Chen S, Wen X, Wang Q, Lv G, Li J, et al. Positive Association between ANKRD55 Polymorphism 7731626 and Dermatomyositis/Polymyositis with Interstitial Lung Disease in Chinese Han Population 2017
  6. 2905987. 6. Gri G, Piconese S, Frossi B, Manfroi V, Merluzzi S, Tripodo C, et al. CD4+CD25+ regulatory T cells suppress mast cell degranulation and allergic responses through OX40-OX40L interaction. Immunity 2008
  7. 771–81. 7. Choi HK, Rho YH, Zhu Y, Cea-Soriano L, Avina-Zubieta JA, Zhang Y. The risk of pulmonary embolism and deep vein thrombosis in rheumatoid arthritis: a UK population-based outpatient cohort study. Ann Rheum Dis 2013
  8. 1182–7. 8. Xu J, Lupu F, Esmon CT. Inflammation, innate immunity and blood coagulation. Hamostaseologie 2010
  9. 5–6. 9. Zoller B, Li X, Sundquist J, Sundquist K. Risk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow-up study from Sweden. Lancet 2012
  10. 244–9. 10. Ramagopalan SV, Wotton CJ, Handel AE, Yeates D, Goldacre MJ. Risk of venous thromboembolism in people admitted to hospital with selected immune-mediated diseases: recordlinkage study. BMC medicine 2011
  11. Erin C. Carruthers, Hyon K. Choi, Eric C. Sayre, J. Antonio AviñaZubieta. Risk of Deep Venous Thrombosis and Pulmonary Embolism in Individuals with Polymyositis and Dermatomyositis: A General Population-Based Study. Ann Rheum Dis 2016
  12. 110–6. 12. Smeeth L, Cook C, Thomas S, Hall AJ, Hubbard R, Vallance P. Lancet. JAMA Intern Med 2013
  13. Risk of deep vein thrombosis and pulmonary embolism after acute infection in a community setting. 2006
  14. 1075–9. 13. Lee YH, Song GG. Idiopathic inflammatory myopathy and the risk of venous thromboembolism: a meta-analysis. 2017
  15. 1165–73. 14. Choi HK, Rho YH, Zh